A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
about
The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cellsLong-term Remission Over Six Years for a Patient with Recurrent Glioblastoma Treated with Cediranib/LomustineAntiangiogenic therapies for glioblastoma.Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.Integrins as Therapeutic Targets: Successes and Cancers.Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin.Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.Evidence and Context of Use for Contrast Enhancement as a Surrogate of Disease Burden and Treatment Response in Malignant Glioma.The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) Resource in Neuro-Oncology.Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.The role of tumor microenvironment in resistance to anti-angiogenic therapy.Glioblastoma Treatments: An Account of Recent Industrial Developments
P2860
Q33648931-B112A372-9BF7-4869-A8E8-28717E666130Q36589454-C214F627-B271-47A3-9788-51B40DE47094Q38264310-D3C8AA5E-B679-4192-BD7B-D8FED6E74D59Q38962315-008E19C5-6BC1-4DC8-A277-330DF48FB25BQ41670949-8BB66AF1-88B7-42EB-990B-D9BAB80CE7CCQ42202016-855DED86-8420-4210-B892-D06069A38899Q44411444-E0A86950-7139-445C-BE5A-5833B501CC7EQ47436703-9876BA63-2591-4E78-862C-1FD4B7D9CF3EQ47755845-D129DE22-1978-4634-8B1D-DCA5C6B14DEFQ52615294-BBD16E09-5051-4CB9-9C5C-D0BD6912D8AFQ52645823-3CE5E9A9-C4D4-49FF-9B60-15BE0A96F50DQ57111067-F592AE6F-D141-420F-B03F-7707E6C292B3
P2860
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A phase I study of cediranib i ...... s with recurrent glioblastoma.
@ast
A phase I study of cediranib i ...... s with recurrent glioblastoma.
@en
type
label
A phase I study of cediranib i ...... s with recurrent glioblastoma.
@ast
A phase I study of cediranib i ...... s with recurrent glioblastoma.
@en
prefLabel
A phase I study of cediranib i ...... s with recurrent glioblastoma.
@ast
A phase I study of cediranib i ...... s with recurrent glioblastoma.
@en
P2093
P2860
P356
P1433
P1476
A phase I study of cediranib i ...... s with recurrent glioblastoma.
@en
P2093
Burt L Nabors
Dan G Duda
Elizabeth R Gerstner
Jeffrey J Olson
Manmeet S Ahluwalia
Michael A Levine
Patrick Y Wen
Rakesh K Jain
Stuart Grossman
Tom Mikkelsen
P2860
P304
P356
10.1093/NEUONC/NOV085
P577
2015-05-24T00:00:00Z